ロード中...
The Cdk5 inhibitor olomoucine promotes corneal debridement wound closure in vivo
PURPOSE: To investigate the effect of the Cdk5 inhibitor olomoucine on corneal debridement wound healing in vivo. METHODS: Corneal debridement wounds of 1.5 mm were made on the ocular surface of CD-1 mice. A 20 μl drop of 15 µM olomoucine in 1% DMSO was applied to the wound area immediately after wo...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Molecular Vision
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2274924/ https://ncbi.nlm.nih.gov/pubmed/18385789 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|